ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Bonnie Lee Hylander
Matched on ORCID iD 0000-0002-0836-1893; OpenAlex author ID A5085199635. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2014: 1 paper · 2015: none · 2016: 2 papers
Papers 3
- Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model. Co-author DOI 10.1158/1535-7163.mct-15-0602↗
- Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. Last author DOI 10.1186/s40425-016-0136-y↗
- Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. First author DOI 10.1038/bjc.2013.754↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert M. Straubinger · 2 shared papers, 2014–2016 · strength 0.11
- Paper Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer M… DOI 10.1158/1535-7163.mct-15-0602↗
- Paper Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. DOI 10.1038/bjc.2013.754↗
- Tista Roy Chaudhuri · 1 shared paper, 2016 · strength 0.07
- Wen Wee Ma · 1 shared paper, 2016 · strength 0.07
- Jason W.‐L. Eng · 1 shared paper, 2016 · strength 0.05
- Thomas A. Mace · 1 shared paper, 2016 · strength 0.05
- W W Ma · 1 shared paper, 2014 · strength 0.05
- Alex A. Adjei · 1 shared paper, 2014 · strength 0.05
- H Zhang · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.